Contents

Current Pharmaceutical Design, Volume 19 - Number 4

Editorial

Editorial (Hot Topic: Cross-Talking Metabolism and Epigenetics in Anti-Cancer Drug Design)

, 19(4): 529 - 531

Alberto Del Rio


DOI: 10.2174/1381612811306040529




Anti-cancer Drug Development: Computational Strategies to Identify and Target Proteins Involved in Cancer Metabolism

, 19(4): 532 - 577

Lora Mak, Sonia Liggi, Lu Tan, Kanthida Kusonmano, Judith M. Rollinger, Alexios Koutsoukas, Robert C. Glen and Johannes Kirchmair


DOI: 10.2174/1381612811306040532




Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives

, 19(4): 578 - 613

Federico Andreoli, Armenio Jorge Moura Barbosa, Marco Daniele Parenti and Alberto Del Rio


DOI: 10.2174/1381612811306040578




Rejuvenating Sirtuins: The Rise of a New Family of Cancer Drug Targets

, 19(4): 614 - 623

Santina Bruzzone, Marco Daniele Parenti, Alessia Grozio, Alberto Ballestrero, Inga Bauer, Alberto Del Rio and Alessio Nencioni


DOI: 10.2174/1381612811306040614




ADP-Ribosylated Proteins as Old and New Drug Targets for Anticancer Therapy: The Example of ARF6

, 19(4): 624 - 633

Nadia Dani, Armenio Jorge Moura Barbosa, Alberto Del Rio and Maria Di Girolamo


DOI: 10.2174/1381612811306040624




Wnt/beta-Catenin Signaling and Small Molecule Inhibitors

, 19(4): 634 - 664

Andrey Voronkov and Stefan Krauss


DOI: 10.2174/1381612811306040634




Glycogen Synthase Kinase 3 as an Anticancer Drug Target: Novel Experimental Findings and Trends in the Design of Inhibitors

, 19(4): 665 - 679

Dmitry I. Osolodkin, Vladimir A. Palyulin and Nikolay S. Zefirov


DOI: 10.2174/1381612811306040665




Genetic and Epigenetic Regulation of Phosphoinositide 3-kinase Isoforms

, 19(4): 680 - 686

Chanse Fyffe, Richard Buus and Marco Falasca


DOI: 10.2174/1381612811306040680




Fibroblast Growth Factor Receptor Inhibitors

, 19(4): 687 - 701

Suneel Kumar B.V.S, Lakshmi Narasu, Rambabu Gundla, Raveendra Dayam and Sarma J.A.R.P


DOI: 10.2174/1381612811306040687




Immunoproteasome in Cancer and Neuropathologies: A New Therapeutic Target?

, 19(4): 702 - 718

Elena Bellavista, Federico Andreoli, Marco Daniele Parenti, Morena Martucci, Aurelia Santoro, Stefano Salvioli, Miriam Capri, Agostino Baruzzi, Alberto Del Rio, Claudio Franceschi and Michele Mishto


DOI: 10.2174/1381612811306040702




Regulation and Function of DNA and Histone Methylations

, 19(4): 719 - 733

Karin Johanna Ferrari and Diego Pasini


DOI: 10.2174/1381612811306040719




New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors

, 19(4): 734 - 744

Michele Cea, Antonia Cagnetta, Marco Gobbi, Franco Patrone, Paul G. Richardson, Teru Hideshima and Kenneth C. Anderson


DOI: 10.2174/1381612811306040734




microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer

, 19(4): 745 - 764

Francesca De Santa, Ilaria Iosue, Alberto Del Rio and Francesco Fazi


DOI: 10.2174/1381612811306040745




Colorectal Cancer Microenvironment: Among Nutrition, Gut Microbiota, Inflammation and Epigenetics

, 19(4): 765 - 778

Paolo Garagnani, Chiara Pirazzini and Claudio Franceschi


DOI: 10.2174/1381612811306040765




Exploring Patterns of Epigenetic Information with Data Mining Techniques

, 19(4): 779 - 789

Vanessa Aguiar-Pulido, Jose A. Seoane, Marcos Gestal and Julian Dorado


DOI: 10.2174/1381612811306040779




Accessing Cancer Metabolic Pathways by the Use of Microarray Technology

, 19(4): 790 - 805

Martin Koch and Michael Wiese


DOI: 10.2174/1381612811306040790




Corrigendum

, 19(4): 806


DOI: 10.2174/1381612811306040806




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science